|
2015
|
Invention
|
Process for the preparation of methyl n-[(benzyloxy)-carbonyl]-l-leucyl-l-phenylalaninate. The pr... |
|
2014
|
Invention
|
Process for the preparation of saxagliptin and its intermediates. The present invention provides ... |
|
|
Invention
|
Multi-layered, multiple unit pharmaceutical compositions. The present invention relates to pharma... |
|
|
Invention
|
Process for the preparation of linagliptin and an intermediate thereof. The present invention pro... |
|
|
Invention
|
Stable oral pharmaceutical composition of solifenacin.
The present invention relates to stable o... |
|
|
Invention
|
Stable oral pharmaceutical composition of solifenacin. The present invention relates to stable or... |
|
|
Invention
|
Low dose pharmaceutical composition of doxycycline.
The present invention relates to a low dose ... |
|
|
Invention
|
Oral compositions of saxagliptin. The present invention relates to oral pharmaceutical compositio... |
|
|
Invention
|
Oral pharmaceutical compositions of saxagliptin. The present invention relates to oral pharmaceut... |
|
|
Invention
|
Oral dispersible composition of a dpp-iv inhibitor.
The present invention relates to oral disper... |
|
|
Invention
|
Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine. The present inven... |
|
|
Invention
|
Pure crystalline form ii of l-malic acid salt of sunitinib and processes for its preparation. The... |
|
|
Invention
|
An ascorbic acid salt of sunitinib. The present invention relates to an ascorbic acid salt of sun... |
|
|
Invention
|
Process for simultaneous drying and micronization of valsartan. The present invention provides a ... |
|
|
Invention
|
Crystalline form of mirabegron. The present invention provides a crystalline form of mirabegron, ... |
|
|
Invention
|
Mirabegron dimethyl sulphoxide solvate and its use for the treatment of overactive bladder. The p... |
|
|
Invention
|
Pharmaceutical composition of vilazodone and processes of preparation thereof. The present invent... |
|
|
Invention
|
Pharmaceutical composition of vilazodone. The present invention relates to pharmaceutical composi... |
|
|
Invention
|
Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one.... |
|
|
Invention
|
Pharmaceutical composition of doxycycline. The present invention relates to a pharmaceutical comp... |
|
|
Invention
|
Extended-release tablets of paliperidone and processes of preparation thereof. The present invent... |
|
|
Invention
|
Pharmaceutical compositions of ticagrelor. The present invention relates to oral pharmaceutical c... |
|
|
Invention
|
Process for the preparation of telaprevir and its intermediates. The present invention provides a... |
|
|
Invention
|
Process for the preparation of telaprevir and intermediates thereof. The present invention provid... |
|
|
P/S
|
pharmaceutical and medicinal preparations for treatment of dermatological conditions |
|
|
Invention
|
An ascorbic acid salt of sunitinib. The present invention relates to an ascorbic acidsalt of suni... |
|
2013
|
Invention
|
Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof. ... |
|
|
Invention
|
Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of es... |
|
|
Invention
|
Process for the preparation of rivaroxaban.
The present invention provides a process for the pre... |
|
|
Invention
|
Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilat... |
|
|
Invention
|
Saxagliptin salts.
The present invention provides saxagliptin bisulphate, saxagliptin acetate, s... |
|
|
Invention
|
Process for the preparation of rivaroxaban.
The present invention provides processes for the pre... |
|
|
Invention
|
Process for the preparation of rivaroxaban and intermediates thereof.
The present invention prov... |
|
|
Invention
|
Process for the preparation of crystalline vilazodone hydrochloride.
The present invention relat... |
|
|
Invention
|
Stabilized controlled-release pharmaceutical composition comprising gliclazide.
The present inve... |
|
|
Invention
|
Taste masked dispersible tablets.
The present invention relates to a taste-masked dispersible ta... |
|
|
Invention
|
Stable dosage forms of imatinib mesylate.
The present invention relates to a stable oral pharmac... |
|
|
Invention
|
Process for the preparation of azilsartan medoxomil or pharmaceutically acceptable salts thereof.... |
|
2012
|
Invention
|
Amorphous vilazodone hydrochloride, a process for its preparation and pharmaceutical compositions... |
|
|
Invention
|
Process for the preparation of polymorphs of doripenem.
The present invention relates to a proce... |
|
|
Invention
|
Process for the preparation of asenapine maleate. The present invention provides a process for th... |
|
|
Invention
|
Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof... |
|
|
Invention
|
Solid dispersions of sitagliptin and processes for their preparation.
The present invention prov... |
|
|
Invention
|
Novel salts of sitagliptin.
The present invention provides sitagliptin 4-methylsalicylate, sitag... |
|
|
Invention
|
Process for the preparation of dexlansoprazole.
The present invention relates to a process for t... |
|
|
Invention
|
Febuxostat solid dispersion.
The present invention provides a solid dispersion of febuxostat, pr... |
|
2011
|
Invention
|
Process for the preparation of malic acid salt of sunitinib.
The present invention relates to a ... |
